IRTC Q2 2022 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena

IRTCiRhythm Technologies, Inc.

$4B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$102M+25.6% YoY

Gross Profit

$70M68.8% margin

Operating Income

-$23M-23.0% margin

Net Income

-$24M-23.4% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+10.5%

Cash Flow

Operating Cash Flow

-$372,000

Free Cash Flow

-$11M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$436M

Total Liabilities

$191M

Stockholders' Equity

$245M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$81M	+25.6%
Gross Profit	$70M	$55M	+27.1%
Operating Income	-$23M	-$17M	-38.0%
Net Income	-$24M	-$17M	-37.7%

Revenue Segments

Commercial Payors

$55M54%

Centers For Medicare And Medicaid

$25M24%

Healthcare Institutions

$16M15%

Non-Contracted Third-Party Payors

$6M6%